« previous next »
Pages: [1]

Author Topic: Long-acting glatiramer acetate (GA Depot) for RRMS and PPMS announced  (Read 205 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9480
  • MS diagnosed 1980
  • Location: Pacific Northwest
Use of GA depot for progressive MS given US patent
« on: June 23, 2022, 09:11:19 pm »

The injection, given every 4 weeks, is intramuscular. The main justification for bringing this new type of glatiramer acetate onto the market seems to be that it would be more convenient for people, and so patient compliance would be improved.

From Multiple Sclerosis News Today (April 2, 2022)--"Use of GA Depot in Treating Progressive MS Given US Patent":


https://multiplesclerosisnewstoday.com/news-posts/2022/04/1/ga-depot-mapi-pharma-given-us-patent-treatment-progressive-ms/
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
158 Views 		Last post February 24, 2018, 09:22:59 am
by agate
1 Replies
203 Views 		Last post April 14, 2018, 03:59:17 pm
by agate
0 Replies
123 Views 		Last post October 24, 2019, 04:29:04 pm
by agate
2 Replies
49 Views 		Last post October 12, 2022, 02:51:43 pm
by agate
0 Replies
16 Views 		Last post November 05, 2022, 09:32:43 pm
by agate